SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-22-013572
Filing Date
2022-08-01
Accepted
2022-08-01 08:38:50
Documents
6
Period of Report
2022-08-01

Document Format Files

Seq Description Document Type Size
1 6-K 6k_dated_80122.htm 6-K 44970
2 EX-99.1 mito-ex99_1.htm EX-99.1 23206
3 EX-99.2 mito-ex99_2.htm EX-99.2 619121
4 EX-99.3 mito-ex99_3.htm EX-99.3 89790
5 EX-99.4 mito-ex99_4.htm EX-99.4 88013
6 EX-99.5 mito-ex99_5.htm EX-99.5 201728
  Complete submission text file 0000950170-22-013572.txt   1067862
Mailing Address 190 ELGIN AVENUE GEORGE TOWN GRAND CAYMAN E9 KY1-9005
Business Address 190 ELGIN AVENUE GEORGE TOWN GRAND CAYMAN E9 KY1-9005 617-600-6888
Stealth BioTherapeutics Corp (Filer) CIK: 0001696396 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38810 | Film No.: 221122924
SIC: 2834 Pharmaceutical Preparations